Zura Bio Ltd (NASDAQ: ZURA) on Friday, plunged -4.24% from the previous trading day, before settling in for the closing price of $3.54. Within the past 52 weeks, ZURA’s price has moved between $2.00 and $7.63.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 75.02%. With a float of $33.14 million, this company’s outstanding shares have now reached $43.59 million.
Let’s look at the performance matrix of the company that is accounted for 15 employees.
Zura Bio Ltd (ZURA) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Zura Bio Ltd is 48.08%, while institutional ownership is 37.11%. The most recent insider transaction that took place on May 17 ’24, was worth 496,000. In this transaction Director of this company bought 80,000 shares at a rate of $6.20, taking the stock ownership to the 100,000 shares. Before that another transaction happened on Apr 22 ’24, when Company’s Director bought 1,186,901 for $3.13, making the entire transaction worth $3,715,000. This insider now owns 1,186,901 shares in total.
Zura Bio Ltd (ZURA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 75.02% per share during the next fiscal year.
Zura Bio Ltd (NASDAQ: ZURA) Trading Performance Indicators
Zura Bio Ltd (ZURA) is currently performing well based on its current performance indicators. A quick ratio of 6.17 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.64, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.80 in one year’s time.
Technical Analysis of Zura Bio Ltd (ZURA)
Zura Bio Ltd (NASDAQ: ZURA) saw its 5-day average volume 0.35 million, a positive change from its year-to-date volume of 0.28 million. As of the previous 9 days, the stock’s Stochastic %D was 17.60%. Additionally, its Average True Range was 0.32.
During the past 100 days, Zura Bio Ltd’s (ZURA) raw stochastic average was set at 31.95%, which indicates a significant increase from 7.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.47% in the past 14 days, which was lower than the 107.21% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.78, while its 200-day Moving Average is $3.98. Nevertheless, the first resistance level for the watch stands at $3.52 in the near term. At $3.65, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.75. If the price goes on to break the first support level at $3.30, it is likely to go to the next support level at $3.20. Assuming the price breaks the second support level, the third support level stands at $3.07.
Zura Bio Ltd (NASDAQ: ZURA) Key Stats
Market capitalization of the company is 216.35 million based on 43,594K outstanding shares. Right now, sales total 0 K and income totals -69,240 K. The company made 0 K in profit during its latest quarter, and -730 K in sales during its previous quarter.
